NerView Surgical Revolutionizes Cancer Surgery with Nerve Visualization Technology

In a significant advancement for cancer surgery, NerView Surgical has clinched the prestigious $100,000 Ernsting Entrepreneurship award at the Falcons' Fortunes 2026 pitch competition held by FACIT. This Ontario-based medtech startup, led by founder and CEO Mann Parikh, showcased its groundbreaking NerveSense™ technology, aimed at improving surgical outcomes for cancer patients.

The Falcons' Fortunes event, now in its thirteenth year, is a key platform for entrepreneurs in the life sciences sector, bringing together innovators with diverse solutions to enhance cancer care. Parikh's pitch illustrated the groundbreaking potential of the NerveSense™ system, a real-time nerve visualization tool that offers surgeons precise localization of nerves during procedures. By minimizing unnecessary nerve damage, this innovative technology has the potential to significantly enhance patient recovery outcomes.

During a packed audience at the pitch event, Parikh articulated how NerveSense™ operates without the use of dyes, making it a safe and non-invasive option for surgeons. The implications for patients are profound—by ensuring the integrity of nerve function, the technology facilitates quicker and more comfortable recoveries, thereby improving patients' quality of life post-surgery.

In addition to the Ernsting award, the competition also recognized Block Biosciences, co-founded by Dr. Agata Kieliszek, with the Audience Choice Award for its innovative approach to treating brain cancer. This highlights a competitive environment filled with groundbreaking ideas aimed at transforming oncology care.

The event's opening remarks were delivered by Jeff Butler, Assistant Deputy Minister at the Ministry of Colleges, Universities, Research Excellence and Security, who underscored Ontario's commitment to advancing life sciences. Following these remarks, a panel discussion featured insights from several successful entrepreneurs in the oncology sector, including Zaid Atto of Xpan and Dr. Saumik Biswas of Tenomix. They shared valuable lessons regarding the commercialization journey and the critical support provided by FACIT, a firm dedicated to fostering innovation in Ontario.

The discussions emphasized the essential resources available for entrepreneurs, particularly the structured and cooperative network that FACIT offers. Both Atto and Biswas, who have previously participated as finalists in Falcons' Fortunes, noted that their experiences have been instrumental in their respective successes. They highlighted how early access to funding, expertise, and networking opportunities offered by FACIT has made a significant difference in their ventures.

Moreover, the contribution of FACIT’s Compass Rose Oncology Fund was highlighted, as it plays a crucial role in filling the funding gap faced by early-stage cancer startups. This acknowledgment of government support for such initiatives indicates a promising future for innovators in Ontario’s healthcare landscape.

“Congratulations to Mann Parikh and the NerView Surgical team, as well as all other finalists in this competitive landscape,” remarked Dr. Nicole Baryla, FACIT’s Senior Director of Corporate Affairs. “We are eager to assist these emerging companies in leveraging our commercialization programs and collaborating with our ecosystem partners.”

In conclusion, NerView Surgical’s accomplishment at this year’s Falcons' Fortunes event is a testament to the innovative spirit of the Ontario medtech community. With technologies like NerveSense™, the future of cancer surgery looks brighter, promising safer, more effective options for patients in need. As these startups navigate their entrepreneurial journeys, the support from FACIT and the wider ecosystem will undoubtedly play a pivotal role in their ongoing successes.

About FACIT

FACIT is a leading commercialization firm focused on accelerating innovations in oncology. Since its inception, it has successfully attracted over $1.7 billion in investments to Ontario, fostering a rich environment for advancements in cancer care. With access to an extensive network of industry experts and resources, FACIT remains committed to supporting entrepreneurs in making meaningful contributions to the field of medicine. More information can be found at facit.ca.